EDIT Q4 2021 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+9.2% YoY

Gross Profit

-$25M-201.2% margin

Operating Income

-$42M-333.7% margin

Net Income

-$41M-332.3% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+101.2%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$37M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$677M

Total Liabilities

$124M

Stockholders' Equity

$554M

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$11M	+9.2%
Gross Profit	-$25M	-$50M	+49.9%
Operating Income	-$42M	-$66M	+36.8%
Net Income	-$41M	-$62M	+33.7%